Ȩ

66¸í

414648¸í

Ȩ>ÀÚ·á½Ç

2013-12¿ù VATS conference

¹®¼º¿ì 2
42
5748307 Á¤´ÙÀº F/24 (Onco ±èÇý·Ãpf / CS ¹è¹Ì°æpf) Multifocal micronodular pneumocyte hyperplasia
 
Brief Hx.
»ó±â 23¼¼ ¿©È¯ Xeroderma pigmentosum °ú°Å·Â ÀÖÀ¸¸ç 2010³â 7¿ù eye lid basal cell carcinoma ·Î excision ½ÃÇàÇÏ¿´À¸¸ç ÀÌÈÄ 2011³â 4¿ù LT proximal tibia Giant cell tumor ·Î curettage ½ÃÇàÇÑ ÈÄ f/u ÇÏ´ø Áß 2012.05.12 chest CT f/u »ó GGO pattern ÀÇ R/O lung meta, breast Rt nodule and both Axillary LNE ¼Ò°ß º¸¿© Breast, both ALN Bx »ó fibroadenoma, unsatisfactory ¼Ò°ß º¸¿© f/u ÇÏ´ø Áß 2013.6.14, 9.25 CT »ó r/o lung mets, rapid growth ÀǽɵǾî 2013.10.2 RUL, RML ÀÇ Wedge resection ½ÃÇà ÈÄ Pathology »ó MMPH ¼Ò°ß º¸ÀÎ ºÐÀÓ.
 
Èí¿¬·Â: none   FHx: Ä£°¡ Á¶ºÎ, Á¶¸ð ¾Ï »ç¸Á
 
¡ß CT Chest HR Study(contrast): 2012.5.12
multiple small GGO or solid nodules in both lungs, but some nodules show increased solid portion
No evidence of lymphadenopathy in the mediastinum and both hilar
enlarged LNs in both axillary fossa
IMP: DDx. multifocal adenocarcinoma with lepidic growth pattern or metastasis.
 
¡ß CT Chest HR Study(contrast): 2013.9.14
multiple small GGO or solid nodules in both lungs, but some nodules show increased solid portion
No evidence of lymphadenopathy in the mediastinum and both hilar
enlarged LNs in both axillary fossa
IMP: DDx. multifocal adenocarcinoma with lepidic growth pattern or metastasis.
 
¡ßBreast Bx & Axillar aspiration pathology (2012.6.11)
- Breast, 9H, left, core biopsy : Fibroadenoma
- Right Axilla Aspirate Cytology : Unsatisfactory for evaluation; Cellular paucity
 
¡ßPostop pathology (2013.10.02)
- Lung, right upper lobe, wedge resection / Lung, right middle lobe, wedge resection
Consistent with multifocal micronodular pneumocyte hyperplasia : RUL, RML
 
 
 
 
 
 
 
 
7715659 ÃÖÃáÀÚ F/66 (Pul ¹Ú¹«¼®pf / CS ÀÌ⿵pf) BOOP, r/o LIP
 
Brief Hx.
»ó±â 66¼¼ ¿©È¯ HTN À¸·Î medication Áß 2013.07.13 dyspnea ÁÖ¼Ò·Î Àϻ꺴¿ø ÀÀ±Þ½Ç °æÀ¯ ÀÔ¿øÇÏ¿© ½ÃÇàÇÑ chest CT »ó cystic lung disease, lymphocytic interstitial pneumonia ¼Ò°ß º¸¿© Ä¡·á Áß Fever develop, º»¿ø Áø·á ¿øÇÏ¿© 7/23 º»¿ø ³»¿ø, Intubation ÈÄ R/O LIP & R/O BOOP ¿¡ ´ëÇÏ¿© TBLB ½ÃÇàÇÏ¿´À¸³ª oraganizing pneumonia ¼Ò°ß º¸À̳ª °Ëü ÃæºÐÇÏÁö ¾Ê¾Æ VATS-biopsy(7/29) ½ÃÇàÇÏ¿´°í, LUL ÀÇ BOOP ¹× LLL ÀÇ Focal peribronchiolar metaplasia ¹× Multifocal subpleural lymphoplasma cell infiltrations ¼Ò°ß º¸ÀÎ ºÐÀÓ
Èí¿¬·Â: negative
¡ßAutoimmune markers(2013.7.23)
-RF quan : <10 IU/mL
-ANA Titration : 1:160w+,1:640-(Homogeneous)
-Anti-DNA Screening : 1:10 negative
-Anti-SS-A/Ro, B/La : Positive(95), Neg
 
¡ß CT Chest HR Study : 2013.7.28
Multiple, variable sized cysts in both lungs, predominant in BLL basal lungs
Multifocal patchy or lobular GGO/consolidations at BUL.
Subpleural peribronchial consolidation at BLL, especially basal lungs.
LIP¿¡¼­ º¸ÀÌ´Â ÀüÇüÀûÀÎ GGO or ill-defined centrilobular opacity ¼Ò°ßÀº º¸ÀÌÁö ¾Ê½À´Ï´Ù.
IMP : Cystic lung disese such as BHD or LIP with combined pneumonia or BOOP.
 
¡ß TBLB & BAL (2013.7.24)
Blind TBLB*3, Pathology: Organizing pneumonia
WBC 1600 (Poly 76%, Mono 22%), CD4 65.8% / CD8 41.9%
 
¡ßPostop pathology (2013.7.30)
-Lung, left upper lobe, biopsy under VATS / Lung, left lower lobe, biopsy under VATS
Lung, left upper lobe: Consistent with bronchiolitis obliterans organizing pneumonia
Lung, left lower lobe:
1. Focal peribronchiolar metaplasia
2. Multifocal subpleural lymphoplasma cell infiltrations
 
¡ßPFT (2013.9.10)
 FVC 1.58(61%), FEV1 1.32(72%), FEV1/FVC 84%, DCLO 8.7mL/mmHg/min (53%)
 
¡ßSalivary scan(2013.9.3)
Decreased uptake in the left parotid and bilateral submandibular glands.
±â°üÁö°æ °Ë»ç °á°ú º¸°í
Duration of benefit in patients with autoimmune PAP after inhaled GM-CSF therapy

±Û¾²±â